BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28488596)

  • 41. Characterization of positively charged polyplexes by tunable resistive pulse sensing.
    Keil TWM; Merkel OM
    Eur J Pharm Biopharm; 2021 Jan; 158():359-364. PubMed ID: 33338601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of Colon Cancer by Degradable rrPPC Nano-Conjugates Delivered STAT3 siRNA.
    Zhang H; Men K; Pan C; Gao Y; Li J; Lei S; Zhu G; Li R; Wei Y; Duan X
    Int J Nanomedicine; 2020; 15():9875-9890. PubMed ID: 33324056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
    Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of a new potential biodegradable disulfide containing poly(ethylene imine)-poly(ethylene glycol) copolymer cross-linked with click cluster for gene delivery.
    Zhao N; Roesler S; Kissel T
    Int J Pharm; 2011 Jun; 411(1-2):197-205. PubMed ID: 21439364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and Application of Low Molecular Weight PEI-Based Copolymers for siRNA Delivery with Smart Polymer Blends.
    Jin Y; Adams F; Möller J; Isert L; Zimmermann CM; Keul D; Merkel OM
    Macromol Biosci; 2023 Feb; 23(2):e2200409. PubMed ID: 36446588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles by a microchannel technology.
    Guo F; Guo D; Zhang W; Yan Q; Yang Y; Hong W; Yang G
    Eur J Pharm Sci; 2017 Mar; 99():328-336. PubMed ID: 28062259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PEGylated polyethyleneimine grafted silica nanoparticles: enhanced cellular uptake and efficient siRNA delivery.
    Lee H; Sung D; Veerapandian M; Yun K; Seo SW
    Anal Bioanal Chem; 2011 Apr; 400(2):535-45. PubMed ID: 21340689
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery.
    Lei Y; Wang J; Xie C; Wagner E; Lu W; Li Y; Wei X; Dong J; Liu M
    J Gene Med; 2013; 15(8-9):291-305. PubMed ID: 24038955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasmid-encapsulated polyethylene glycol-grafted polyethylenimine nanoparticles for gene delivery into rat mesenchymal stem cells.
    Chen XA; Zhang LJ; He ZJ; Wang WW; Xu B; Zhong Q; Shuai XT; Yang LQ; Deng YB
    Int J Nanomedicine; 2011; 6():843-53. PubMed ID: 21589652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Folic Acid/Peptides Modified PLGA-PEI-PEG Polymeric Vectors as Efficient Gene Delivery Vehicles: Synthesis, Characterization and Their Biological Performance.
    Liu C; Xie Y; Li X; Yao X; Wang X; Wang M; Li Z; Cao F
    Mol Biotechnol; 2021 Jan; 63(1):63-79. PubMed ID: 33141343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Photoluminescent and biodegradable polycitrate-polyethylene glycol-polyethyleneimine polymers as highly biocompatible and efficient vectors for bioimaging-guided siRNA and miRNA delivery.
    Wang M; Guo Y; Yu M; Ma PX; Mao C; Lei B
    Acta Biomater; 2017 May; 54():69-80. PubMed ID: 28219808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
    Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A
    Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
    Darvishi MH; Nomani A; Amini M; Shokrgozar MA; Dinarvand R
    Int J Pharm; 2013 Nov; 456(2):408-16. PubMed ID: 24012865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells.
    Sardo C; Bassi B; Craparo EF; Scialabba C; Cabrini E; Dacarro G; D'Agostino A; Taglietti A; Giammona G; Pallavicini P; Cavallaro G
    Int J Pharm; 2017 Mar; 519(1-2):113-124. PubMed ID: 28093325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
    Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
    Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy.
    Lee SY; Yang CY; Peng CL; Wei MF; Chen KC; Yao CJ; Shieh MJ
    Biomaterials; 2016 Apr; 86():92-105. PubMed ID: 26896610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polycation-detachable nanoparticles self-assembled from mPEG-PCL-g-SS-PDMAEMA for in vitro and in vivo siRNA delivery.
    Lin D; Jiang Q; Cheng Q; Huang Y; Huang P; Han S; Guo S; Liang Z; Dong A
    Acta Biomater; 2013 Aug; 9(8):7746-57. PubMed ID: 23624221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes.
    Kim SH; Lee SH; Tian H; Chen X; Park TG
    J Drug Target; 2009 May; 17(4):311-7. PubMed ID: 19242850
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance.
    Merkel OM; Beyerle A; Librizzi D; Pfestroff A; Behr TM; Sproat B; Barth PJ; Kissel T
    Mol Pharm; 2009; 6(4):1246-60. PubMed ID: 19606864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.